Edward Holmes

Holmes Edward

Appointment(s)
  • Professor, Department of Medicine
Joint Appointment(s)
  • Distinguished Professor, University of California, USA
  • Vice Chancellor/Dean Emeritus, University of California, San Diego, USA
  • Senior Fellow, A*STAR
  • Advisor, National Research Foundation, Singapore
Academic Qualifications
  • MD, University of Pennsylvania, USA
  • BS, Washington and Lee University, USA
Research Interest(s)
  • Molecular Medicine
  • Stem Cell Research
Recent Publications
  • 1. Cheng J, Morisaki H, Toyama K, Sugimoto N, Shintani T, Tandelilin A, Hirase T, Holmes EW, Morisaki T. 2014 Dec. AMPD1: A novel therapeutic target for reversing insulin resistance. BMC Endocrine Disorders. 14(1). doi: 10.1186/1472-6823-14-96.
  • 2. Cheng J, Morisaki H, Sugimoto N, Dohi A, Shintani T, Kimura E, Toyama K, Ikawa M, Okabe M, Higuchi I et al. 2014 Jan. Effect of isolated AMP deaminase deficiency on skeletal muscle function. Molecular Genetics and Metabolism Reports. 1(1):51-59. doi: 10.1016/j.ymgmr.2013.12.004.
  • 3. Naiara Akizu, Vincent Cantagrel, Jana Schroth, Na Cai, Keith Vaux, Douglas McCloskey, Robert K. Naviaux, Jeremy Van Vleet, Ali G. Fenstermaker, Jennifer L. Silhavy, Judith S. Scheliga, Keiko Toyama, Hiroko Morisaki, Fatma Mujgan Sonmez, Figen Celep, Azza Oraby, Maha S. Zaki, Raidah Al-Baradie, Eissa Faqeih, Mohammad Saleh, Emily Spencer, Rasim Ozgur Rosti, Eric Scott, Elizabeth Nickerson, Stacey Gabriel, Takayuki Morisaki, Edward W. Holmes, and Joseph G. Gleeson. 2013 Aug. AMPD 2 Regulates GTP Synthesis and Is Mutated in a Potentially Treatable Neurodegenerative Brainstem Disorder. Cell 154(3):505-517.